Skip to main content

and
  1. Article

    Open Access

    Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses

    Several recent phase 3 clinical trials of attention-deficit/hyperactivity disorder (ADHD) medications have used the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P). Here, we assess WFIRS-P res...

    David R. Coghill, Tamara Werner-Kiechle in European Child & Adolescent Psychiatry (2021)

  2. Article

    Open Access

    Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

    SPD489-404 was the first 2-year safety study of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. In accordance with advice from the European...

    David R. Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson in CNS Drugs (2018)